Incidental Mutation 'R0021:Psmb9'
ID 19012
Institutional Source Beutler Lab
Gene Symbol Psmb9
Ensembl Gene ENSMUSG00000096727
Gene Name proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)
Synonyms Lmp-2, Lmp2
MMRRC Submission 038316-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.212) question?
Stock # R0021 (G1)
Quality Score
Status Validated
Chromosome 17
Chromosomal Location 34401006-34406347 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to A at 34403277 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Alanine to Valine at position 80 (A80V)
Ref Sequence ENSEMBL: ENSMUSP00000133499 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000041633] [ENSMUST00000170086] [ENSMUST00000171321] [ENSMUST00000173831] [ENSMUST00000174576]
AlphaFold no structure available at present
Predicted Effect probably benign
Transcript: ENSMUST00000041633
SMART Domains Protein: ENSMUSP00000039264
Gene: ENSMUSG00000037321

DomainStartEndE-ValueType
transmembrane domain 5 27 N/A INTRINSIC
transmembrane domain 37 59 N/A INTRINSIC
transmembrane domain 66 88 N/A INTRINSIC
transmembrane domain 116 138 N/A INTRINSIC
Pfam:ABC_membrane 163 420 9.1e-55 PFAM
AAA 478 666 2.21e-18 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000114230
Predicted Effect noncoding transcript
Transcript: ENSMUST00000166287
Predicted Effect noncoding transcript
Transcript: ENSMUST00000166853
Predicted Effect probably benign
Transcript: ENSMUST00000170086
SMART Domains Protein: ENSMUSP00000128401
Gene: ENSMUSG00000037321

DomainStartEndE-ValueType
transmembrane domain 5 27 N/A INTRINSIC
transmembrane domain 37 59 N/A INTRINSIC
transmembrane domain 66 88 N/A INTRINSIC
transmembrane domain 116 138 N/A INTRINSIC
Pfam:ABC_membrane 163 434 5.8e-70 PFAM
AAA 506 694 2.21e-18 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000171321
Predicted Effect probably benign
Transcript: ENSMUST00000173831
AA Change: A57V

PolyPhen 2 Score 0.049 (Sensitivity: 0.94; Specificity: 0.83)
SMART Domains Protein: ENSMUSP00000134120
Gene: ENSMUSG00000096727
AA Change: A57V

DomainStartEndE-ValueType
Pfam:Proteasome 1 64 2.3e-17 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000174576
AA Change: A80V

PolyPhen 2 Score 0.261 (Sensitivity: 0.91; Specificity: 0.88)
SMART Domains Protein: ENSMUSP00000133499
Gene: ENSMUSG00000096727
AA Change: A80V

DomainStartEndE-ValueType
Pfam:Proteasome 17 198 1.2e-45 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000178857
Predicted Effect noncoding transcript
Transcript: ENSMUST00000179593
Meta Mutation Damage Score 0.1126 question?
Coding Region Coverage
  • 1x: 84.2%
  • 3x: 78.9%
  • 10x: 65.7%
  • 20x: 50.3%
Validation Efficiency 96% (92/96)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 1 (proteasome beta 6 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. [provided by RefSeq, Mar 2010]
PHENOTYPE: Mice homozygous for disruptions in this gene have a grossly normal phenotype but suffer from increased susceptibility to some viruses and have an increased risk of tumor development. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 42 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
2310016G11Rik A G 7: 44,326,620 (GRCm39) noncoding transcript Het
Abcc5 T A 16: 20,197,411 (GRCm39) K647* probably null Het
Aplp1 A G 7: 30,135,241 (GRCm39) probably benign Het
Baiap3 T C 17: 25,462,643 (GRCm39) E1105G probably damaging Het
Brinp3 T G 1: 146,777,189 (GRCm39) S545R probably benign Het
Btnl1 A G 17: 34,598,468 (GRCm39) E28G probably benign Het
Ccr6 G A 17: 8,475,598 (GRCm39) V268M possibly damaging Het
Clstn1 G A 4: 149,719,253 (GRCm39) V361M probably damaging Het
Col1a2 G A 6: 4,518,822 (GRCm39) probably benign Het
D630045J12Rik G A 6: 38,160,902 (GRCm39) Q1081* probably null Het
Dhx15 T C 5: 52,314,830 (GRCm39) T626A probably damaging Het
Dhx36 T C 3: 62,385,016 (GRCm39) I699V possibly damaging Het
Dnah9 A G 11: 65,860,805 (GRCm39) I2855T probably benign Het
Duxf4 C A 10: 58,071,385 (GRCm39) E276D probably benign Het
Fsip2 T A 2: 82,830,201 (GRCm39) probably benign Het
Galnt11 A T 5: 25,453,855 (GRCm39) D27V probably damaging Het
Gm5134 T A 10: 75,829,718 (GRCm39) C335S probably damaging Het
Hdhd2 A T 18: 77,058,311 (GRCm39) K227N probably damaging Het
Itgb4 A T 11: 115,870,453 (GRCm39) D94V possibly damaging Het
Krtcap3 A G 5: 31,410,303 (GRCm39) H227R probably benign Het
Macf1 T C 4: 123,369,370 (GRCm39) H232R probably damaging Het
Map2k4 A G 11: 65,603,110 (GRCm39) I174T probably damaging Het
Mcc C G 18: 44,652,583 (GRCm39) probably benign Het
Mcm9 G A 10: 53,413,997 (GRCm39) T1099I possibly damaging Het
Nkapd1 A C 9: 50,521,725 (GRCm39) D65E probably damaging Het
Nqo2 T C 13: 34,165,490 (GRCm39) I129T probably benign Het
Pdgfrb T A 18: 61,197,998 (GRCm39) probably benign Het
Phf7 C T 14: 30,960,443 (GRCm39) probably benign Het
Plac8 T A 5: 100,704,434 (GRCm39) T88S probably benign Het
Prss52 T G 14: 64,341,857 (GRCm39) V16G probably benign Het
Ptprk T A 10: 28,468,891 (GRCm39) V1425E probably damaging Het
Scart2 G A 7: 139,876,310 (GRCm39) R594H probably benign Het
Scn2a T C 2: 65,500,859 (GRCm39) V7A possibly damaging Het
Serpini1 T C 3: 75,526,620 (GRCm39) Y291H probably damaging Het
Setd6 A G 8: 96,443,293 (GRCm39) K19E probably damaging Het
Siah2 T C 3: 58,583,713 (GRCm39) H191R probably benign Het
Slc27a2 T C 2: 126,409,806 (GRCm39) probably benign Het
Tbc1d10a T C 11: 4,163,680 (GRCm39) C277R probably damaging Het
Trim55 A C 3: 19,698,866 (GRCm39) M32L probably benign Het
Unc5b T C 10: 60,614,698 (GRCm39) T200A probably benign Het
Wrap53 A T 11: 69,454,712 (GRCm39) M219K probably damaging Het
Zfp790 G A 7: 29,525,113 (GRCm39) probably benign Het
Other mutations in Psmb9
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02008:Psmb9 APN 17 34,402,653 (GRCm39) missense probably damaging 1.00
bias UTSW 17 34,402,199 (GRCm39) nonsense probably null
preconception UTSW 17 34,402,588 (GRCm39) critical splice donor site probably null
R0105:Psmb9 UTSW 17 34,406,249 (GRCm39) missense probably benign
R0477:Psmb9 UTSW 17 34,401,238 (GRCm39) missense probably damaging 0.99
R3919:Psmb9 UTSW 17 34,402,588 (GRCm39) critical splice donor site probably null
R5898:Psmb9 UTSW 17 34,401,266 (GRCm39) missense probably damaging 0.97
R5943:Psmb9 UTSW 17 34,403,265 (GRCm39) missense probably damaging 0.99
R6408:Psmb9 UTSW 17 34,404,707 (GRCm39) missense probably damaging 1.00
R6919:Psmb9 UTSW 17 34,402,199 (GRCm39) nonsense probably null
R8512:Psmb9 UTSW 17 34,402,602 (GRCm39) missense probably benign
R9105:Psmb9 UTSW 17 34,401,905 (GRCm39) intron probably benign
R9304:Psmb9 UTSW 17 34,406,222 (GRCm39) critical splice donor site probably null
R9454:Psmb9 UTSW 17 34,402,078 (GRCm39) missense probably benign 0.00
R9633:Psmb9 UTSW 17 34,402,119 (GRCm39) missense probably damaging 1.00
Posted On 2013-03-25